J Vissing Selected Research

Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)

1/2020	No effect of oral sucrose or IV glucose during exercise in phosphorylase b kinase deficiency.
1/2012	Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?
5/2008	Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Vissing Research Topics

Disease

5	Glycogen Storage Disease Type V (McArdle's Disease) 10/2016 - 12/2001
4	Muscular Diseases (Myopathy) 01/2018 - 05/2008
3	Glycogen Storage Disease Type Ix 01/2020 - 05/2008
3	Mitochondrial Myopathies (Mitochondrial Myopathy) 12/2009 - 01/2001
2	Muscular Dystrophies (Muscular Dystrophy) 12/2019 - 07/2013
2	Myositis (Idiopathic Inflammatory Myopathies) 05/2018 - 01/2008
2	Glycogen Storage Disease Type II (Pompe's Disease) 01/2018 - 01/2017
2	Glycogen Storage Disease (Glycogenosis) 04/2017 - 01/2012
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 12/2016 - 05/2008
2	Polymyositis 10/2016 - 01/2008
2	Dermatomyositis (Dermatopolymyositis) 12/2013 - 01/2008
1	Oculopharyngeal Muscular Dystrophy 08/2022
1	Deglutition Disorders (Dysphagia) 08/2022
1	Inclusion Body Myositis 08/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2019
1	Muscle Cramp (Cramp) 05/2018
1	Hypertrophy 05/2018
1	Myalgia 05/2018
1	Rhabdomyolysis 05/2018
1	Glycogen Storage Disease XIV 04/2017
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 04/2017
1	Muscle Weakness 10/2016
1	Atrophy 10/2016
1	Migraine Disorders (Migraine) 01/2016
1	Hyperparathyroidism 01/2015
1	Myotonic Dystrophy (Dystrophia Myotonica) 09/2014
1	Facioscapulohumeral muscular dystrophy 1a 09/2013
1	Medium chain acyl CoA dehydrogenase deficiency 04/2013
1	Type 2 Diabetes Mellitus (MODY) 05/2012
1	Hypercalcemia (Milk Alkali Syndrome) 05/2012
1	Asymptomatic Diseases 01/2012
1	Myoclonic dystonia 05/2008
1	VLCAD deficiency 07/2007
1	Type 2I Limb-Girdle Muscular Dystrophy 01/2007
1	Leukoencephalopathies 09/2002
1	Deafness (Deaf Mutism) 10/2001
1	Intellectual Disability (Idiocy) 10/2001
1	Cataract (Cataracts) 10/2001
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2001
1	Epilepsy (Aura) 10/2001
1	Acidosis 05/2001

Drug/Important Bio-Agent (IBA)

4	Lactic Acid (Lactate)FDA LinkGeneric 05/2008 - 01/2001
3	Phosphorylase Kinase (Phosphorylase Kinase, Glycogen)IBA 01/2020 - 05/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 07/2007
3	Mitochondrial DNA (mtDNA)IBA 12/2019 - 10/2001
3	GlycogenIBA 01/2012 - 05/2008
2	Proteins (Proteins, Gene)FDA Link 04/2017 - 12/2008
2	Dystroglycans (Dystroglycan)IBA 12/2016 - 07/2013
2	Oxygen (Dioxygen)IBA 12/2013 - 01/2007
2	CarbohydratesIBA 02/2009 - 12/2008
1	Botulinum Toxins (Botulinum Toxin)IBA 08/2022
1	Sucrose (Saccharose)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 05/2018
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 05/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 05/2018
1	alpha-Glucosidases (Acid Maltase)IBA 01/2018
1	EnzymesIBA 01/2018
1	PhosphoglucomutaseIBA 04/2017
1	Galactose (Galactopyranose)FDA LinkGeneric 04/2017
1	Adenosine Triphosphate (ATP)IBA 10/2016
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2015
1	NucleotidesIBA 09/2014
1	VimentinIBA 09/2013
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2013
1	Carnitine (L-Carnitine)FDA LinkGeneric 04/2013
1	AndrogensIBA 05/2012
1	Testosterone (Sustanon)FDA Link 05/2012
1	PalmitatesIBA 02/2009
1	IsotopesIBA 02/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2009
1	Nonesterified Fatty Acids (NEFA)IBA 02/2009
1	Sarcoglycans (beta Sarcoglycan)IBA 05/2008
1	Methotrexate (Mexate)FDA LinkGeneric 01/2008
1	Pharmaceutical PreparationsIBA 01/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008
1	Infliximab (Remicade)FDA Link 01/2008
1	Triglycerides (Triacylglycerol)IBA 07/2007
1	DNA (Deoxyribonucleic Acid)IBA 09/2002
1	AmmoniaIBA 12/2001
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 10/2001
1	Cytochromes b (Cytochrome b)IBA 10/2001
1	Interleukin-6 (Interleukin 6)IBA 01/2001

Therapy/Procedure

2	Endurance Training 12/2009 - 01/2007
1	Injections 08/2022
1	Enzyme Replacement Therapy 01/2017
1	Resistance Training 10/2016
1	Therapeutics 10/2016
1	Stem Cell Transplantation 10/2016